Study approval
SECONDARY
The study was carried out according to GCP, approved by the Swedish Ethics Review Authority (Dnr. 2019-01510) and the Swedish Medicinal Products Agency, and preregistered as EudraCT 2018-004829-82. Data for secondary analyses will be made available with a transfer agreement.